Armstrong, V.W.

patient transplantation mycophenolate mofetil transplant mycophenolic acid mycophenolate study recipient concentration mofetil mycophenolic pharmacokinetic diarrhea transplant recipients acmpag mpa auc 0–12 metabolite group glucuronide mmf dose value plasma 0–12 1000 mg mmf exposure visit mpa cl /f diarrhoea month level signi ficantly regimen armstrong vw table conditioning signi episode +++ range cyclosporine figure incidence mpa exposure mmf doses analysis concentration-time signi ficant differences cl /f mpa-auc hct recipients tcl /mmf difference shipkova blood fi xed dose nonmyeloablative conditioning donor curve plasma concentrations comparison pharmacokinetic assessment hematopoietic nonmyeloablative monit csa /mmf enterohepatic recycling case report tacrolimu sample cell transplantation biliary excretion event ficantly ficant administration signi ficant difference american concentration-time curves result dosing